Evidence map›Paper›PMID 39168975›Full record

ArticleNature communications2024

In-depth analysis of transcriptomes in ovarian cortical follicles from children and adults reveals interfollicular heterogeneity.

Ilmatar Rooda, Jasmin Hassan, Jie Hao, Magdalena Wagner, Elisabeth Moussaud-Lamodière, Kersti Jääger, Marjut Otala, Katri Knuus, Cecilia Lindskog, Kiriaki Papaikonomou and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ilmatar RoodaDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden. ilmatar.rooda@ki.se.ORCID 0000-0002-5594-4987
Jasmin HassanDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.ORCID 0000-0002-5583-3291
Jie HaoDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.ORCID 0000-0003-4839-665X
Magdalena WagnerDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.ORCID 0000-0002-6266-1248
Elisabeth Moussaud-LamodièreDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.ORCID 0000-0002-2359-6519
Kersti JäägerInstitute of Computer Science, University of Tartu, Tartu, Estonia.ORCID 0000-0002-0503-9292
Marjut OtalaDepartment of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-7914-8897
Katri KnuusDepartment of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-4725-9728
Cecilia LindskogDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-5611-1015
Kiriaki PapaikonomouDepartment of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-0862-6265
Sebastian GidlöfDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.
Cecilia LangenskiöldDepartment of Pediatric Oncology, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID 0000-0002-4327-8526
Hartmut VogtCrown Princess Victoria Children's Hospital, and Division of Children's and Women's Health, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID 0000-0001-6009-7789
Per FriskDepartment of Women's and Children's Health, Uppsala University Children's Hospital, Uppsala, Sweden.
Johan MalmrosAstrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Timo TuuriDepartment of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0734-3244
Andres SalumetsDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden.ORCID 0000-0002-1251-8160
Kirsi JahnukainenChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-9296-2028
Agne Velthut-MeikasDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.ORCID 0000-0003-1927-9016
Pauliina DamdimopoulouDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden. pauliina.damdimopoulou@ki.se.ORCID 0000-0001-8458-0855

Funding

Barncancerfonden (Swedish Childhood Cancer Foundation) KP2020-0012Barncancerfonden (Swedish Childhood Cancer Foundation) PR2020-0096EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 825100EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) EU952516Eesti Teadusagentuur (Estonian Research Council) PRG1076Eesti Teadusagentuur (Estonian Research Council) PSG608Vetenskapsrådet (Swedish Research Council) 2020-02132Vetenskapsrådet (Swedish Research Council) 2021-00079
6 · The paper itself

Abstract

The ovarian cortical reserve of follicles is vital for fertility. Some medical treatments are toxic to follicles, leading to premature ovarian insufficiency. Ovarian tissue cryopreservation is an established method to preserve fertility in adults and even applied in prepuberty despite unproven efficacy. Here, we analyze transcriptomes of 120 cortical follicles from children and adults for detailed comparison. We discover heterogeneity with two main types of follicles in both age groups: one with expected oocyte-granulosa profiles and another with predicted role in signaling. Transcriptional changes during growth to the secondary stage are similar overall in children and adults, but variations related to extracellular matrix, theca cells, and miRNA profiles are found. Notably, cyclophosphamide dose correlates with interferon signaling in child follicles. Additionally, morphology alone is insufficient for follicle categorization suggesting a need for additional markers. Marker genes for early follicle activation are determined. These findings will help refine follicular classification and fertility preservation techniques across critical ages.

Indexed as

Ovarian FollicleTranscriptomeAdolescentAdultChildChild, PreschoolCryopreservationCyclophosphamideFemaleFertility PreservationGene Expression ProfilingHumansMicroRNAsOocytesSignal TransductionCyclophosphamideMicroRNAs

Identifiers

PMID39168975
PMCPMC11339373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.